Please provide your email address to receive an email when new articles are posted on . Hudson and colleagues conducted a meta-analysis of 35 studies of trials of testosterone vs. placebo for ...

Meta-analysis of data from more than 3,400 patients with hypogonadism from 17 clinical trials finds little evidence that testosterone treatment increases the risk of cardiovascular events such as ...

Testosterone replacement therapy appears safe in the short-to-medium term to treat a condition caused by deficiency of the male sex hormone, according to the most comprehensive analysis of the ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

Men with hypogonadism see no added risk of cardiovascular events when taking testosterone, at least over the relatively short term, a meta-analysis of placebo-controlled, randomized trials suggests.

A low serum testosterone level at baseline was associated with higher risk for all-cause and cardiovascular disease (CVD) mortality, a meta-analysis of 11 prospective cohort studies found. In ...

Testosterone is the main sex hormone in male vertebrates and is part of the steroid group of hormones. It circulates in the bloodstream and accumulates in various tissues. Scientists have previously ...

A new analysis of published research suggests that testosterone therapy may aid many post-menopausal women dealing with loss of libido. The analysis -- labeled a position statement from the North ...